Summary
In a significant market movement during March 2025, Trimtech Therapeutics was the subject of a vc funding. The transaction achieved a gross valuation of £24,205,162. Leading the round was Start Codon, Eli lilly and company, Pfizer Ventures, Cambridge Enterprise Ventures, MP Healthcare Venture Management, Dementia Discovery Fund, M Ventures, Cambridge Innovation Capital.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Start Codon
Lead Investor / Acquirer
Eli lilly
Lead Investor / Acquirer
company
Lead Investor / Acquirer
Pfizer Ventures
Lead Investor / Acquirer
Cambridge Enterprise Ventures
Lead Investor / Acquirer
MP Healthcare Venture Management
Lead Investor / Acquirer
Dementia Discovery Fund
Lead Investor / Acquirer
M Ventures
Lead Investor / Acquirer
Cambridge Innovation Capital
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in